Comparison of multiple pain management regimes in total knee joint replacement a randomized control trial study
Not Applicable
- Conditions
- Health Condition 1: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2019/03/018239
- Lead Sponsor
- sunshine hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients scheduled to undergo unilateral TKA under spinal anaesthesia .
Exclusion Criteria
Bilateral
Epidural / GA
Creatinine > 1.2 , renal or hepatic dysfunction.
Allergic to any study medication , chronic opiod use , BMI >40
Chronic pain unrelated to knee joint
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Pain Score : VAS (Visual Analog Score) <br/ ><br> <br/ ><br>2. Knee ROM. <br/ ><br> <br/ ><br>3. Ambulation distance <br/ ><br>4 .Opiate Consumption at 12 ,24,48 hrs.( calculation in morphine equivalents) <br/ ><br>5. Anti Emetics usage <br/ ><br>6. Timing of breakthrough medication (IV paracetamol) <br/ ><br>7. Length of stay <br/ ><br>8. Discharge day <br/ ><br>9. Patient satisfaction. <br/ ><br>10. Active Quadriceps holding time <br/ ><br> <br/ ><br>Timepoint: 1.Pain Score : VAS (Visual Analog Score) <br/ ><br> <br/ ><br>2. Knee ROM. <br/ ><br> <br/ ><br>3. Ambulation distance <br/ ><br>4 .Opiate Consumption at 12 ,24,48 hrs.( calculation in morphine equivalents) <br/ ><br>5. Anti Emetics usage <br/ ><br>6. Timing of breakthrough medication (IV paracetamol) <br/ ><br>7. Length of stay <br/ ><br>8. Discharge day <br/ ><br>9. Patient satisfaction. <br/ ><br>10. Active Quadriceps holding time <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method noneTimepoint: none